The DSM-5-TR (Diagnostic and Statistical Manual of Mental Disorders, 5th Edition, Text Revision) is the diagnostic standard used by psychiatrists, psychologists, and licensed therapists across the United States. Every psychiatric diagnosis in a patient's chart traces back to it — which is why "DSM-5 criteria" is one of the most-searched clinical queries in the country.
Quick answer: The DSM-5-TR is the American Psychiatric Association's diagnostic manual for mental disorders. Each diagnosis lists lettered criteria (A–E), specifiers, and an ICD-10-CM code used on claims. This guide tabulates the most-searched DSM-5-TR diagnoses — mood, anxiety, trauma, OCD-spectrum, neurodevelopmental, psychotic, and substance use — with their criteria and codes.
📄 Free download: DSM-5-TR Diagnostic Criteria Quick-Reference Cheat Sheet (Printable PDF) — a 2-page desk reference covering the top outpatient diagnoses with symptom counts, duration thresholds, ICD-10-CM codes, and paired screeners.
This guide is a quick-reference companion: the disorders clinicians look up most often, their diagnostic codes, and the core criteria in scannable tables. Use it during intake, differential diagnosis, and documentation.
What DSM-5-TR Is — and Why It Matters for Billing
The DSM-5-TR (Text Revision, 2022) is published by the American Psychiatric Association (APA) and is the diagnostic standard for every US psychiatrist, psychologist, and licensed therapist. It defines roughly 160 disorders through explicit, lettered criteria — a diagnosis is made when the documented clinical picture satisfies the criteria, not by intuition alone.
Three practical facts every clinician should know:
- DSM-5-TR codes are ICD-10-CM codes. The manual uses F-codes (and some G-codes) directly, so the diagnosis you document maps one-to-one onto the code on the superbill, claim, and encounter note. ICD-11 exists internationally, but US billing runs on ICD-10-CM.
- Criteria-based diagnosis is audit-defensible. Payers verify that documented symptoms match the billed diagnosis. Writing "meets DSM-5-TR criteria for..." with the specific symptoms documented is what survives a records request.
- Specifiers carry clinical weight. Severity, course, and feature specifiers (e.g., "with anxious distress," "in partial remission") support medical necessity, E/M complexity, and treatment planning — even though they don't generate separate billing codes.
How DSM-5-TR Is Organized
DSM-5-TR groups disorders into chapters. Each diagnosis lists criteria lettered A through E (or more), followed by specifiers (severity, course, subtype) and ICD-10-CM codes.
| Chapter | Covers | Example diagnoses |
|---|---|---|
| Neurodevelopmental | ADHD, autism, intellectual disability, learning disorders | ADHD, Autism Spectrum Disorder |
| Schizophrenia Spectrum & Other Psychotic | Schizophrenia, schizoaffective, delusional, brief psychotic | Schizophrenia (F20.x) |
| Bipolar & Related | Bipolar I, Bipolar II, cyclothymic, substance-induced | Bipolar I Disorder (F31.x) |
| Depressive Disorders | MDD, persistent depressive, premenstrual dysphoric, substance-induced | Major Depressive Disorder (F32/F33.x) |
| Anxiety Disorders | GAD, panic, social anxiety, specific phobia, agoraphobia | Generalized Anxiety Disorder (F41.1) |
| Obsessive-Compulsive & Related | OCD, body dysmorphic, hoarding, trichotillomania, excoriation | OCD (F42.x) |
| Trauma & Stressor-Related | PTSD, acute stress disorder, adjustment disorder, reactive attachment | PTSD (F43.10–F43.12) |
| Dissociative Disorders | Dissociative identity, amnesia, depersonalization/derealization | Dissociative Identity Disorder (F44.81) |
| Somatic Symptom & Related | Somatic symptom disorder, illness anxiety, conversion, factitious | Somatic Symptom Disorder (F45.1) |
| Feeding & Eating | Anorexia, bulimia, binge eating, avoidant/restrictive | Anorexia Nervosa (F50.0x) |
| Elimination Disorders | Enuresis, encopresis | Enuresis (F98.0) |
| Sleep-Wake Disorders | Insomnia, hypersomnolence, narcolepsy, breathing-related, parasomnias | Insomnia Disorder (G47.00) |
| Sexual Dysfunctions | Desire, arousal, orgasmic, pain disorders, paraphilic | Female Sexual Interest/Arousal Disorder (F52.22) |
| Gender Dysphoria | Gender dysphoria in children/adolescents/adults | Gender Dysphoria (F64.x/F65.x) |
| Disruptive, Impulse-Control & Conduct | ODD, intermittent explosive, conduct disorder, kleptomania, gambling | ODD (F91.3) |
| Substance-Related & Addictive | Alcohol, cannabis, stimulant, opioid, tobacco, gambling use disorders | Alcohol Use Disorder (F10.x) |
| Neurocognitive | Delirium, major/mild neurocognitive (dementia) | Major Neurocognitive Disorder (F02/F03/F05) |
| Personality Disorders | Cluster A (odd), B (dramatic), C (anxious) | Borderline Personality Disorder (F60.3) |
| Paraphilic Disorders | Voyeuristic, exhibitionistic, pedophilic, etc. | Pedophilic Disorder (F65.4) |
Master Quick-Reference Table
| Disorder | DSM-5-TR / ICD-10-CM | Core criteria (summary) |
|---|---|---|
| Major Depressive Disorder | F32.x–F33.x | ≥5 of 9 symptoms (incl. depressed mood or anhedonia), same 2-week period, clinically significant distress/impairment |
| Persistent Depressive Disorder | F34.1 | Depressed mood most of the day, more days than not, ≥2 years (1 year in children), plus ≥2 additional symptoms |
| Bipolar I Disorder | F31.x | ≥1 manic episode (≥7 days or any duration if hospitalized); manic = elevated/irritable mood + ≥3 (or 4 if only irritability) associated symptoms |
| Bipolar II Disorder | F31.81 | ≥1 hypomanic + ≥1 major depressive episode; no full manic episode |
| Cyclothymic Disorder | F34.0 | ≥2 years of hypomanic + depressive symptoms, never meeting full episode criteria |
| Generalized Anxiety Disorder | F41.1 | Excessive anxiety/worry more days than not for ≥6 months, difficult to control, + ≥3 associated symptoms |
| Panic Disorder | F41.0 | Recurrent unexpected panic attacks + ≥1 month of persistent concern about additional attacks or maladaptive change in behavior |
| Social Anxiety Disorder | F40.10 | Marked fear/anxiety about social situations where scrutiny is possible, out of proportion, avoidance or endured with intense distress, ≥6 months |
| Specific Phobia | F40.2xx | Marked fear/anxiety about a specific object/situation, object/situation almost always provokes fear, active avoidance, ≥6 months, no better explanation |
| Agoraphobia | F40.00 | Marked fear/anxiety about ≥2 of: public transport, open spaces, enclosed spaces, crowds, being alone outside home; avoidance or need for companion |
| PTSD | F43.10/.11/.12 | Exposure to actual/threatened death, serious injury, or sexual violence + intrusion + avoidance + negative alterations + arousal symptoms; >1 month duration; distress/impairment |
| Acute Stress Disorder | F43.0 | PTSD symptom clusters lasting 3 days–1 month after trauma exposure |
| Adjustment Disorder | F43.2x | Emotional/behavioral symptoms within 3 months of identifiable stressor, out of proportion, clinically significant distress/impairment; resolves within 6 months of stressor ending |
| OCD | F42.x | Recurrent intrusive obsessions and/or compulsive behaviors; time-consuming (>1 hr/day) or clinically significant distress/impairment |
| Body Dysmorphic Disorder | F45.22 | Preoccupation with perceived appearance flaws, repetitive behaviors/mental acts, clinically significant distress/impairment |
| Hoarding Disorder | F42.3 | Persistent difficulty discarding/parting with possessions regardless of value, resulting in accumulation; clinically significant distress/impairment or unsafe living conditions |
| Trichotillomania | F63.3 | Recurrent pulling out of hair resulting in hair loss; attempts to decrease; clinically significant distress/impairment |
| Excoriation (Skin-Picking) Disorder | F42.4 | Recurrent skin picking resulting in skin lesions; attempts to decrease; clinically significant distress/impairment |
| ADHD — Combined | F90.2 | ≥6 symptoms each of inattention + hyperactivity/impulsivity (≥5 if age 17+), onset before 12, across ≥2 settings, clinically significant impairment |
| ADHD — Inattentive | F90.0 | ≥6 inattentive symptoms only (≥5 if 17+), same onset/cross-setting/impairment requirements |
| ADHD — Hyperactive-Impulsive | F90.1 | ≥6 hyperactive/impulsive symptoms only (≥5 if 17+), same requirements |
| Autism Spectrum Disorder | F84.0 | Persistent deficits in social communication/social interaction + restricted, repetitive patterns of behavior; present in early development; clinically significant impairment |
| Schizophrenia | F20.x | ≥2 of: delusions, hallucinations, disorganized speech, grossly disorganized/catatonic behavior, negative symptoms; ≥6 months total, ≥1 month active-phase; functional decline |
| Schizoaffective Disorder | F25.x | Uninterrupted period of illness with major mood episode + ≥2 weeks of delusions/hallucinations without mood episode + schizophrenia-criterion symptoms overall |
| Delusional Disorder | F22 | ≥1 month of delusions without other psychotic symptoms; functioning not markedly impaired outside delusion's impact |
| Brief Psychotic Disorder | F23 | Delusions/hallucinations/disorganized speech or grossly disorganized behavior lasting 1 day–1 month, with return to premorbid functioning |
| Schizophreniform Disorder | F20.81 | Schizophrenia-criterion symptoms lasting 1–6 months |
| Anorexia Nervosa | F50.0x | Restriction of energy intake → significantly low body weight; intense fear of gaining weight/becoming fat; disturbance in body weight/shape self-evaluation; restricting type or binge-eating/purging type |
| Bulimia Nervosa | F50.2 | Recurrent binge eating (large amount + loss of control) + recurrent inappropriate compensatory behaviors, ≥1/week for 3 months; self-evaluation unduly influenced by body shape/weight |
| Binge-Eating Disorder | F50.81 | Recurrent binge episodes (no compensatory behaviors), ≥1/week for 3 months, marked distress, 3+ associated features |
| Insomnia Disorder | G47.00 | Dissatisfaction with sleep quantity/quality with sleep initiation/maintenance/early awakening problems, ≥3 nights/week for ≥3 months, daytime impairment, occurs despite adequate sleep opportunity |
| Narcolepsy | G47.41 | Daily excessive daytime sleepiness ≥3 months + either cataplexy + MSLT findings, or MSLT findings alone (mean sleep latency ≤8 min + ≥2 SOREMPs) |
| Alcohol Use Disorder | F10.x | ≥2 of 11 criteria in 12 months: larger/longer use, persistent desire/failed efforts, time spent, cravings, failure to fulfill roles, social problems, activities given up, hazardous use, continued use despite problems, tolerance, withdrawal |
| Cannabis Use Disorder | F12.x | Same 11-criterion framework as other substance use disorders |
| Opioid Use Disorder | F11.x | Same framework; specifiers: on maintenance agonist therapy / in remission / severe |
| Borderline Personality Disorder | F60.3 | Pervasive pattern of instability in interpersonal relationships, self-image, affects + marked impulsivity; ≥5 of 9 criteria |
| Antisocial Personality Disorder | F60.2 | Pervasive disregard for/violation of rights of others since age 15, with conduct disorder before 15 |
| Major Neurocognitive Disorder | F02.x/F03.9/F05 | Significant cognitive decline from prior level in ≥1 domain (complex attention, executive, learning/memory, language, perceptual-motor, social cognition) that interferes with independence |
Mood & Anxiety Criteria — Quick Look
Major Depressive Disorder — Criteria Summary
| Criterion | Requirement |
|---|---|
| A | ≥5 symptoms during the same 2-week period, representing change from prior functioning; at least one is either (1) depressed mood or (2) loss of interest/pleasure |
| Symptoms pool | Depressed mood; anhedonia; significant weight change/appetite change; insomnia or hypersomnia; psychomotor agitation/retardation; fatigue; worthlessness/guilt; diminished concentration; recurrent thoughts of death/suicidal ideation/attempt/plan |
| B | Symptoms cause clinically significant distress or impairment in social, occupational, or other important areas |
| C | Episode not attributable to substances or another medical condition |
| D | Not better explained by psychotic disorder, schizophrenia spectrum, delusional disorder, or other specified/unspecified schizophrenia spectrum disorder |
| Specifiers | With anxious distress, mixed features, melancholic features, atypical features, mood-congruent/mood-incongruent psychotic features, catatonia, peripartum onset, seasonal pattern; severity: mild/moderate/severe; in partial/full remission; recurrent episode vs. single episode |
For severity bands, the ≥10 positive-screen cutoff, and CPT 96127 documentation of MDD screening, see the PHQ-9 & GAD-7 Score Interpretation Guide.
Generalized Anxiety Disorder — Criteria Summary
| Criterion | Requirement |
|---|---|
| A | Excessive anxiety and worry, occurring more days than not for ≥6 months, about a number of events/activities |
| B | The individual finds it difficult to control the worry |
| C | ≥3 of: restlessness/feeling keyed up/on edge; being easily fatigued; difficulty concentrating; irritability; muscle tension; sleep disturbance (only 1 required in children) |
| D | Anxiety/worry not better explained by another mental disorder |
| E | Not attributable to substances or another medical condition |
| F | Clinically significant distress or impairment |
| Specifiers | With or without panic attacks |
For live GAD-7 scoring with severity bands and the ≥10 cutoff workflow, use the GAD-7 Score Interpretation & Calculator.
Panic Disorder — Criteria Summary
| Criterion | Requirement |
|---|---|
| A | Recurrent unexpected panic attacks (≥2 in a 4-week period, or at least one followed by ≥1 month of persistent concern) |
| B | ≥1 month (or until presentation) of at least one: persistent concern about additional attacks; worry about implications of attack or its consequences; significant maladaptive change in behavior related to attacks |
| C | Not attributable to substances/medical condition or another mental disorder |
| Specifiers | Panic attack specifier applies to any diagnosis when panic attacks are present |
Differential Diagnosis and Comorbidity — Mood & Anxiety
Depressive and anxiety disorders overlap heavily, and the criteria tables above don't capture the judgment calls:
| Presentation clue | Consider | Rule out |
|---|---|---|
| Depressed mood + worry about many things | MDD with anxious distress | GAD (worry predates and outlasts mood episodes) |
| Panic attacks only in social situations | Social anxiety disorder | Panic disorder (attacks must be unexpected, not cue-bound) |
| Low mood for 2+ years, never severe | Persistent depressive disorder | MDD, recurrent (discrete episodes) |
| Anxiety + flashbacks after a stressor | PTSD | GAD (worry is generalized, not trauma-cued) |
| Mood elevation + decreased need for sleep | Bipolar I/II | ADHD, stimulant use, hyperthyroidism |
Comorbidity is the rule, not the exception: roughly 60% of patients with depression meet anxiety criteria at some point, and substance use disorders co-occur with mood disorders at similar rates. Document each diagnosis that independently meets criteria — comorbid diagnoses are billable and clinically actionable.
When to refer: refer to psychiatry when there is psychotic features, treatment resistance (two adequate trials failed), active suicidality with plan or intent, complex polypharmacy, or diagnostic uncertainty spanning multiple chapters. Primary care can manage mild-to-moderate depression and anxiety with screening, measurement-based follow-up, and first-line pharmacotherapy.
Trauma & Stressor-Related Disorders
PTSD — Criteria Summary
| Criterion | Requirement |
|---|---|
| A | Exposure to actual or threatened death, serious injury, or sexual violence: (1) direct experience; (2) witnessing in person; (3) learning of violent/accidental death of close family/friend; (4) repeated/extreme exposure to aversive details (first responders excluded) |
| B | Intrusion symptoms (≥1): recurrent distressing memories; distressing dreams; flashbacks; intense/prolonged distress at cues; marked physiological reactions |
| C | Avoidance (≥1): avoidance of trauma-related thoughts/feelings; avoidance of external reminders |
| D | Negative alterations in cognition/mood (≥2): amnesia for trauma aspects; negative beliefs about self/world/others; distorted blame; persistent negative emotional state; diminished interest; detachment; inability to experience positive affect |
| E | Marked alterations in arousal/reactivity (≥2): irritability/aggression; reckless/destructive behavior; hypervigilance; exaggerated startle; concentration problems; sleep disturbance |
| F | Duration >1 month |
| G | Clinically significant distress or impairment |
| H | Not attributable to substances or another medical condition |
| Specifiers | With or without dissociative symptoms (depersonalization/derealization); with delayed expression (full criteria met >6 months after event); acute (<3 months) vs. chronic (≥3 months); severity: mild/moderate/severe |
Acute Stress Disorder
| Criterion | Requirement |
|---|---|
| Duration | 3 days to 1 month after trauma exposure (distinguishes from PTSD, which requires >1 month) |
| Symptoms | Same intrusion/negative mood/dissociation/avoidance/arousal clusters as PTSD, plus dissociative symptoms (depersonalization, derealization, amnesia, sense of unreality/estrangement) |
Adjustment Disorder
| Criterion | Requirement |
|---|---|
| A | Emotional or behavioral symptoms in response to identifiable stressor(s) occurring within 3 months of stressor onset |
| B | Distress out of proportion to severity/frequency of stressor; significant impairment in social/occupational/functioning |
| C | Stress-related distress does not meet criteria for another mental disorder |
| D | Once stressor or consequences have terminated, symptoms do not persist for more than 6 months |
| Specifiers | With depressed mood, with anxiety, with mixed anxiety and depressed mood, with disturbance of conduct, with mixed disturbance of emotions and conduct, unspecified |
PTSD vs. Adjustment Disorder vs. Complex Trauma — Getting the Code Right
| Question | PTSD | Acute Stress Disorder | Adjustment Disorder |
|---|---|---|---|
| Trauma exposure required? | Yes — criterion A (death, serious injury, sexual violence) | Yes — same criterion A | No — any identifiable stressor (divorce, job loss, illness) qualifies |
| Duration | >1 month | 3 days–1 month | Within 3 months of stressor; resolves within 6 months of stressor ending |
| Symptom structure | Fixed clusters B–E | Same clusters + dissociative symptoms | Flexible — mood, anxiety, conduct, or mixed |
| Code | F43.10–F43.12 | F43.0 | F43.2x |
Complex PTSD ("DESNOS") is not a separate DSM-5-TR diagnosis — severe, prolonged interpersonal trauma with disturbances in self-organization is coded as PTSD with the "other specified trauma- and stressor-related disorder" designation (F43.8) or documented as PTSD with associated features. The ICD-11 has a distinct complex PTSD code (6B41), but US claims use the DSM-5-TR mapping.
Delayed expression matters for billing: if full criteria are met more than 6 months after the event, use the "with delayed expression" specifier — auditors flag PTSD codes attached to charts with no documented trauma timeline.
Obsessive-Compulsive & Related Disorders
OCD — Criteria Summary
| Criterion | Requirement |
|---|---|
| A | Presence of obsessions, compulsions, or both |
| Obsessions | Recurrent and persistent thoughts, urges, or images that are experienced as intrusive and unwanted, and that in most individuals cause marked anxiety or distress; the individual attempts to ignore, suppress, or neutralize them with some other thought or action |
| Compulsions | Repetitive behaviors (e.g., hand washing, ordering, checking) or mental acts (e.g., praying, counting, repeating words silently) that the individual feels driven to perform in response to an obsession or according to rigid rules; aimed at preventing/reducing anxiety or preventing a dreaded event; not realistically connected to the feared outcome or are clearly excessive |
| B | The obsessions/compulsions are time-consuming (e.g., >1 hour per day in total) OR cause clinically significant distress or impairment |
| C | Not attributable to substances or another medical condition |
| D | Not better explained by another mental disorder (e.g., generalized anxiety, body dysmorphic disorder, eating disorders, trichotillomania) |
| Specifiers | With good or fair insight / with poor insight / with absent insight/delusional beliefs; tic-related or without tic-related specifier; past or current tic disorder |
Note: DSM-5-TR removed the DSM-IV "OCD with poor insight" specifier hierarchy in favor of the three insight levels above — poor/absent insight is common and does not exclude the diagnosis.
Related Disorders at a Glance
| Disorder | DSM-5-TR Code | Core feature |
|---|---|---|
| Body Dysmorphic Disorder | F45.22 | Preoccupation with perceived appearance flaws + repetitive behaviors/mental acts |
| Hoarding Disorder | F42.3 | Persistent difficulty discarding possessions → unsafe/unsanitary accumulation |
| Trichotillomania | F63.3 | Recurrent hair pulling with hair loss |
| Excoriation Disorder | F42.4 | Recurrent skin picking with skin lesions |
| Olfactory Reference Syndrome | F45.8 (other specified) | Preoccupation with perceived body odor |
Neurodevelopmental Disorders
ADHD — Criteria Summary
| Criterion | Requirement |
|---|---|
| A1 — Inattention (≥6 symptoms if <17 yrs; ≥5 if 17+) | Often fails to give close attention; difficulty sustaining attention; does not listen when spoken to; does not follow through on instructions; difficulty organizing tasks; avoids/dislikes sustained mental effort; loses things; easily distracted; forgetful in daily activities |
| A2 — Hyperactivity/Impulsivity (same thresholds) | Fidgets/taps/squirms; leaves seat when expected to remain; runs/climbs inappropriately; unable to play quietly; "on the go"/restless; talks excessively; blurts out answers; difficulty waiting turn; interrupts/intrudes |
| B | Several inattentive or hyperactive-impulsive symptoms were present before age 12 |
| C | Several symptoms present in ≥2 settings (e.g., home, school, work) |
| D | Clear evidence symptoms interfere with or reduce quality of functioning in social, academic, or occupational settings |
| E | Symptoms not better explained by another mental disorder and do not occur exclusively during schizophrenia spectrum, bipolar, or other psychotic disorder |
| Specifiers | Combined presentation / predominantly inattentive / predominantly hyperactive-impulsive; in partial/full remission; mild/moderate/severe; adult presentation; unspecified presentation |
Autism Spectrum Disorder — Criteria Summary
| Criterion | Requirement |
|---|---|
| A | Persistent deficits in social communication and social interaction across contexts (all three required): (1) deficits in social-emotional reciprocity; (2) deficits in nonverbal communicative behaviors; (3) deficits in developing/maintaining/understanding relationships |
| B | Restricted, repetitive patterns of behavior/interests/activities (≥2 of 4): stereotyped/repetitive motor movements or speech; insistence on sameness/inflexible routines; highly restricted fixated interests of abnormal intensity/focus; hyper- or hyporeactivity to sensory input |
| C | Symptoms must be present in the early developmental period (may not fully manifest until social demands exceed capacities) |
| D | Symptoms cause clinically significant impairment in social, occupational, or other important areas of current functioning |
| E | Not better explained by intellectual disability or global developmental delay; social communication deficits exceed what would be expected given general developmental level |
| Specifiers | With or without accompanying intellectual impairment; with or without accompanying language impairment; associated with another neurodevelopmental, mental, or behavioral disorder; with catatonia; severity level 1/2/3 (requiring support/substantial support/very substantial support) |
Psychotic Spectrum — Quick Reference
| Disorder | DSM-5-TR Code | Distinguishing feature |
|---|---|---|
| Schizophrenia | F20.x | ≥6 months, ≥1 month active phase; negative symptoms; functional decline |
| Schizophreniform | F20.81 | Same symptom criteria, 1–6 months duration |
| Brief Psychotic | F23 | 1 day–1 month, full return to functioning |
| Schizoaffective | F25.x | Mood episode + ≥2 weeks psychosis without mood symptoms |
| Delusional Disorder | F22 | ≥1 month delusions only; functioning preserved outside delusion |
| Substance/Medication-Induced Psychotic | F1x.5/F05 | Psychosis temporally related to substance use or medical condition |
| Psychotic Disorder Due to GMC | F06.2 | Psychosis attributable to another medical condition |
Duration Rules and Rule-Outs — The Psychotic Spectrum Decision Path
The psychotic-spectrum diagnoses are distinguished almost entirely by duration and comorbid mood symptoms:
| Duration of active symptoms | Mood episodes present? | Diagnosis |
|---|---|---|
| 1 day–1 month, full recovery | No | Brief Psychotic Disorder (F23) |
| 1–6 months | No | Schizophreniform Disorder (F20.81) |
| ≥6 months (≥1 month active) | No | Schizophrenia (F20.x) |
| Any | Mood episode + ≥2 weeks psychosis without mood | Schizoaffective Disorder (F25.x) |
| ≥1 month, delusions only | No | Delusional Disorder (F22) |
Mood vs. psychosis precedence: if psychotic symptoms occur only during mood episodes, the diagnosis is a mood disorder with psychotic features — not schizoaffective. Schizoaffective requires ≥2 weeks of delusions or hallucinations in the absence of a major mood episode.
Always rule out before coding a psychotic disorder:
- Substances — stimulant intoxication, cannabis-induced psychosis, steroid-induced psychosis (urine drug screen, medication review)
- Medical conditions — thyroid disease, autoimmune encephalitis, temporal lobe epilepsy, delirium (basic labs, neuro exam)
- Developmental context — autism spectrum with atypical presentation is not psychosis
Substance-Related & Addictive Disorders — Framework
All substance use disorders share the same 11-criterion framework (≥2 in 12 months = diagnosis; 2–3 mild, 4–5 moderate, ≥6 severe):
| # | Criterion |
|---|---|
| 1 | Taken in larger amounts or over longer period than intended |
| 2 | Persistent desire or unsuccessful efforts to cut down/stop |
| 3 | Great deal of time spent obtaining, using, recovering |
| 4 | Craving, or strong desire to use |
| 5 | Recurrent use resulting in failure to fulfill major role obligations |
| 6 | Continued use despite persistent/recurrent social or interpersonal problems caused by use |
| 7 | Important social, occupational, or recreational activities given up or reduced |
| 8 | Recurrent use in physically hazardous situations |
| 9 | Continued use despite knowledge of persistent/recurrent physical or psychological problem likely caused by substance |
| 10 | Tolerance (marked increase in amount needed, or markedly diminished effect) |
| 11 | Withdrawal (characteristic syndrome, or substance taken to relieve withdrawal) |
| Substance class | DSM-5-TR codes | Notes |
|---|---|---|
| Alcohol | F10.10–F10.99 | Includes alcohol-induced disorders (intoxication, withdrawal, mood/anxiety/psychotic/neurocognitive disorders) |
| Cannabis | F12.x | Withdrawal recognized; cannabis-induced anxiety/psychotic disorders common |
| Stimulants (cocaine, amphetamine) | F14.x, F15.x | Intoxication and withdrawal can mimic mood/psychotic disorders |
| Opioids | F11.x | Includes heroin, prescription opioids; medication for opioid use disorder (MOUD) specifiers apply |
| Sedatives/Hypnotics/Anxiolytics | F13.x | Cross-tolerance with alcohol/benzos |
| Tobacco/Nicotine | F17.x | Withdrawal syndrome defined; cessation pharmacotherapy specifiers |
| Gambling Disorder | F63.0 | Only behavioral addiction in DSM-5-TR (placed in disruptive/impulse-control chapter) |
Neurocognitive Disorders — Quick Reference
| Disorder | DSM-5-TR Code | Key point |
|---|---|---|
| Delirium | F05 | Acute fluctuating disturbance in attention/awareness, develops over hours–days, tends to fluctuate; due to substance, GMC, or multiple etiologies |
| Major Neurocognitive Disorder | F02.x/F03.9/F05 | Significant decline in ≥1 cognitive domain interfering with independence (dementia-level impairment) |
| Mild Neurocognitive Disorder | G31.84 | Modest decline in ≥1 domain, preserved independence with greater effort/compensation |
| Alzheimer's Disease | G30.9 + F02.81 | Most common major NCD; biomarker support possible (amyloid PET, CSF, plasma) |
| Vascular NCD | F01.x | Cognitive decline temporally related to cerebrovascular disease |
| Lewy Body Disease | G31.83 + F02.80 | Fluctuating cognition, visual hallucinations, parkinsonism; severe antipsychotic sensitivity |
| Frontotemporal NCD | G31.09 + F02.80 | Prominent personality/behavior change or language impairment, relatively preserved memory early |
Screening Instruments Mapped to Diagnoses
Validated brief screens exist for most high-prevalence diagnoses. A positive screen supports — but never replaces — a clinical interview.
| Diagnosis | Validated screeners | Notes |
|---|---|---|
| Depression | PHQ-9, PHQ-2 | PHQ-2 ≥3 → full PHQ-9; PHQ-9 ≥10 positive |
| Anxiety (GAD) | GAD-7 | GAD-7 ≥10 positive; also screens panic/social anxiety |
| PTSD | PCL-5 | PCL-5 ≥33 provisional PTSD diagnosis |
| ADHD (adults) | ASRS-v1.1 (WHO) | Part A score ≥4 → further evaluation |
| OCD | Y-BOCS (severity), OCI-R/DOCS (screening) | Y-BOCS measures severity, not diagnosis |
| Bipolar | MDQ | MDQ ≥7 symptoms + co-occurrence + functional impact |
| Alcohol use | AUDIT / AUDIT-C | AUDIT ≥8 (men) / ≥4 (women) positive; AUDIT-C ≥4 men / ≥3 women |
| Cognitive impairment | MoCA, MMSE | MoCA preferred for mild impairment sensitivity |
| Eating disorders | SCOFF | ≥2 positive answers → further evaluation |
For detailed scoring tables on PHQ-9 and GAD-7, see the PHQ-9 & GAD-7 Score Interpretation Guide, the PHQ-9 Scoring Guide, and the GAD-7 Score Interpretation & Calculator. For ADHD, PTSD, and OCD criteria walkthroughs, see DSM-5 Criteria: ADHD, PTSD & OCD Screening. Deep dives on the remaining high-demand diagnoses: DSM-5-TR Bipolar I & II Criteria & F31 Code Map, ASD & Schizophrenia Criteria, and OCD Criteria & Y-BOCS Scoring. Prefer a printable desk copy? Grab the DSM-5-TR Cheat Sheet (Free Printable PDF).
ICD-10-CM vs. DSM-5-TR Codes
DSM-5-TR uses ICD-10-CM codes directly as its diagnostic codes (F-codes for mental disorders), so the code on a superbill, claim, or encounter note maps directly to the DSM-5-TR diagnosis. Specifiers (severity, course, with/without features) are captured in documentation but do not generate separate billing codes.
Documentation and Billing: Making Criteria Survive an Audit
How Specifiers Affect E/M Complexity
Evaluation-and-management coding rewards documented complexity. Specifiers are where that documentation lives:
| Documented element | E/M impact |
|---|---|
| Severity specifier (mild/moderate/severe) | Supports higher MDM (medical decision-making) level for moderate/severe |
| "With anxious distress," "with mixed features" | Documents comorbidity burden — supports complexity |
| "In partial remission" vs. active | Justifies visit frequency changes and transition planning |
| Recurrent vs. single episode | Recurrent MDD (F33.x) supports ongoing management visits |
Why "Unspecified" vs. Specified Matters for Payer Audits
Payers increasingly flag unspecified diagnoses (e.g., F41.9 "anxiety disorder, unspecified," F39 "mood disorder, unspecified") on behavioral health claims:
- Unspecified codes suggest incomplete evaluation — a common denial trigger for therapy and psychiatric E/M claims
- If criteria for a specific disorder are genuinely not yet established (first visit, incomplete history), document the working diagnosis and the plan to specify it
- "Other specified" (e.g., F43.8) is preferable to "unspecified" when the clinical picture is clear but doesn't fit a named disorder
CPT 96127 — Billing for Screening Administration
When staff administer and score screening instruments (PHQ-9, GAD-7, PCL-5, ASRS), the work is billable under CPT 96127 — psychological or neuropsychological test administration with scoring by a practice staff member under physician or qualified healthcare professional supervision, per hour of staff time:
| Rule | Detail |
|---|---|
| Time rule | Per hour of staff time; 16-minute minimum (one unit typically covers a screening session) |
| Frequency | Most payers allow one unit per patient per day |
| Same-day E/M | Generally billable alongside an E/M visit — document the screening separately |
| Documentation | Instrument name, date, raw score, interpretation, staff time, supervising provider |
| Typical reimbursement | Roughly $1–2 per unit (varies by payer) |
Documentation Best Practices for Criteria-Based Diagnoses
- Name the criteria, not just the code — "meets DSM-5-TR criteria for MDD, recurrent, moderate (F33.1): depressed mood, anhedonia, insomnia, fatigue, impaired concentration × 3 months"
- Document the duration explicitly — PTSD >1 month, GAD ≥6 months, ADHD onset before 12
- Record functional impairment — a required criterion in nearly every diagnosis; specific work/school/social impact
- Separate screening from diagnosis — a PHQ-9 score of 18 is a screen result, not a diagnosis; the interview findings establish the diagnosis
- Keep specifiers current — update severity and remission status at each visit
Frequently Asked Questions
What is the difference between DSM-5 and DSM-5-TR?
DSM-5-TR (Text Revision, 2022) is a text update to DSM-5 — it clarifies criteria language, adds ICD-10-CM coding updates, and revises some disorder criteria (notably prolonged grief disorder added, some criteria wording clarified). The disorder structure is unchanged.
Is DSM-5 the same as ICD-10?
No. DSM-5-TR is the psychiatric diagnostic manual; ICD-10-CM is the medical billing/coding system used on claims. DSM-5-TR uses ICD-10-CM codes for mental disorders, so they align for psychiatric diagnoses — but ICD-10-CM also covers all non-psychiatric medicine.
Can a diagnosis be made from a screening score alone?
No. Screening instruments (PHQ-9, GAD-7, PCL-5, ASRS) identify patients who need evaluation. Diagnosis requires a clinical interview establishing DSM-5-TR criteria. Document the screen result AND the interview findings separately.
Where can I administer these screeners digitally?
Neuraline's AI Screening module ships with the standardized instruments pre-seeded — PHQ-9, GAD-7, Y-BOCS, BDI, HAM-D, MMSE, AUDIT, and CAGE — with automated scoring, severity bands, and alert thresholds. Assign them in the patient portal or administer during encounters; scores, severity, and AI interpretation land on the chart automatically, and 3-click AI Charting drafts the encounter note with the results included. See the screening feature.
This reference summarizes DSM-5-TR diagnostic criteria for educational use. It is not a substitute for the full manual or clinical judgment. Always verify criteria against the current DSM-5-TR text and your state scope-of-practice rules.
Ready to streamline psychiatric documentation? Schedule a demo of Neuraline's screening, encounter templates, and e-prescribing.
About Neuraline
Neuraline (neura-line.com) is an AI-powered Electronic Health Record (EHR), practice management, and medical billing platform for independent healthcare practices.
